![Nicole van der Weerden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicole van der Weerden
Directeur Général chez
AROVELLA THERAPEUTICS LIMITED
Profil
Nicole Louise van der Weerden is Chief Executive & Operating Officer at Arovella Therapeutics Ltd. since 2026.
Formerly, Dr. van der Weerden was Non-Executive Director at Hexima Ltd. from 2022 to 2023.
Education includes an MBA and a doctorate from Melbourne Business School, and a doctorate from La Trobe University conferred in 2007.
Postes actifs de Nicole van der Weerden
| Sociétés | Poste | Début |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Directeur Général | 07/05/2026 |
Anciens postes connus de Nicole van der Weerden
| Sociétés | Poste | Fin |
|---|---|---|
| HEXIMA LIMITED | Directeur Général | 31/12/2022 |
Formation de Nicole van der Weerden
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Melbourne Business School
 Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hexima Ltd.
 Hexima Ltd. BiotechnologyHealth Technology Engages in research and development of plant-derived proteins for treatment of fungal nail infections and provides commercial property services | Health Technology |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
LaTrobe University
 LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
